Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000267400, dynein, light chain, roadblock-type 2 pseudogene, is a non-functional genomic element resulting from duplication or retrotransposition of the DYNLRB2 gene. Pseudogenes are typically not transcribed into functional protein and do not participate in biological or therapeutic processes. The true functional protein, Dynein light chain roadblock-type 2 (DYNLRB2), is a component of the cytoplasmic dynein complex, involved in microtubule-based intracellular transport. Pseudogenes may provide indirect evidence of genome evolution but are not considered therapeutic or diagnostic targets. This entity is a pseudogene and not a functional gene product; it is not considered a therapeutic target, receptor, enzyme, transporter, or other actionable protein. The specific entity ENSG00000267400 is not a protein-coding gene but a pseudogene, meaning it does not produce a functional molecule. There is a related protein-coding gene, DYNLRB2, but ENSG00000267400 refers only to its non-functional duplicate. Pseudogenes do not have an active biological function. The parent gene, DYNLRB2, participates in microtubule-based movement as a dynein accessory subunit. No disease role for the pseudogene. The functional DYNLRB2 gene is associated with diseases such as deafness and Bardet-Biedl syndrome, but the pseudogene has no known clinical relevance. No drugs interact with pseudogenes. Therapeutic targeting is only relevant for protein-coding, functional molecules. No mechanism of action for pseudogenes. Not used as a biomarker. The functional DYNLRB2 gene has some association with hepatocellular carcinoma, but not its pseudogene. No safety concerns relevant for pseudogenes. In summary, ENSG00000267400 is a non-functional pseudogene, not a receptor or drug target, with no biological roles, disease associations, or clinical applications. For structured data or scientific research, reference DYNLRB2 for the functional gene, not the pseudogene ENSG00000267400.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynein, light chain, roadblock-type 2 pseudogene (DYNLRB2 pseudogene).